Reuters logo
BRIEF-Roche, Lilly drugs chosen for trial to prevent early-onset Alzheimer's
October 10, 2012 / 1:35 PM / 5 years ago

BRIEF-Roche, Lilly drugs chosen for trial to prevent early-onset Alzheimer's

Oct 10 (Reuters) - washington University in St. Louis: * Says Roche drug gantenerumab, Eli Lilly’s solanezumab chosen for

alzheimer’s prevention trial -- Washington university * Lilly beta secretase inhibitor also selected for potential inclusion

in global trial - Washington university * Trial expected to begin early 2013 to test three drugs; each target

alzheimer’s in different way -- Washington university * Trial to be conducted at Washington university by dominantly inherited

alzheimer’s network trials unit (dian tu) -- Washington university * Trial to involve 160 people with inherited gene mutations that typically lead

to alzheimer’s at young age -- Washington university

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below